{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:22:49Z","timestamp":1772166169861,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Little is known about perceptions, use intentions, and behaviors of adults regarding nicotine gum that is marketed and regulated as a consumer product rather than as a medicinal nicotine replacement therapy (NRT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Survey data were collected from a Qualtrics online panel (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u20091000) of adults who had never used a consumer nicotine gum, recruited based on smoking behavior, and from current and former purchasers of one commercially available nicotine gum product (LUCY Chew and Park), recruited via emails to a customer database (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u2009500). In addition to descriptive cross-sectional analyses, logistic regression was used to estimate the probability of intent to try and of product appeal among these different groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among online panel respondents, individuals who smoked with and without plans to quit showed high intention to try the product (odds ratios 15.6 [95% CI 9.3, 27.6] and 9.8 [95% CI 5.8, 17.3] respectively, compared to people who formerly smoked) and persons who had never smoked showed low intentions to try. These results stood regardless of flavor. Among current and former purchasers of the study product, 43.4% of persons who had smoked cigarettes regularly indicated they were motivated to try the product \u201cto help me quit smoking.\u201d Only 0.6% of young adult consumers of the nicotine gum (aged 21\u201330) had not tried tobacco products previously.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Consumer nicotine gum does not appear to attract those who have never used a tobacco product and the results for young adults suggest minimal appeal to youth. The study product was used primarily by individuals who currently smoke and\/or use e-cigarettes but who wished to quit or reduce consumption. These results suggest that a consumer nicotine gum may reduce harm by substituting for higher-risk products such as combustible cigarettes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12954-023-00864-0","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T23:21:50Z","timestamp":1694560910000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Perceptions, intentions, and actual use of a consumer nicotine gum"],"prefix":"10.1186","volume":"20","author":[{"given":"Cheryl K.","family":"Olson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Sherwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maia","family":"Berkane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Gilligan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Willie J.","family":"McKinney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,13]]},"reference":[{"issue":"10292","key":"864_CR1","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1016\/S0140-6736(21)01169-7","volume":"397","author":"MB Reitsma","year":"2021","unstructured":"Reitsma MB, Kendrick PJ, Ababneh E, Abbafati C, Abbasi-Kangevari M, Abdoli A, et al. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990\u20132019: a systematic analysis from the Global Burden of Disease Study 2019. The Lancet. 2021;397(10292):2337\u201360.","journal-title":"The Lancet"},{"key":"864_CR2","doi-asserted-by":"crossref","first-page":"106567","DOI":"10.1016\/j.ypmed.2021.106567","volume":"150","author":"LJ Rosen","year":"2021","unstructured":"Rosen LJ, Galili T, Kott J, Rees V. Beyond, \u201cSafe and Effective\u201d: the urgent need for high-impact smoking cessation medications. Prev Med. 2021;150:106567.","journal-title":"Prev Med"},{"issue":"4","key":"864_CR3","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1136\/tc.2008.027318","volume":"18","author":"M Zeller","year":"2009","unstructured":"Zeller M, Hatsukami D. Strategic dialogue on tobacco harm reduction G. The strategic dialogue on tobacco harm reduction: a vision and blueprint for action in the US. Tob Control. 2009;18(4):324\u201332.","journal-title":"Tob Control"},{"key":"864_CR4","doi-asserted-by":"crossref","first-page":"106099","DOI":"10.1016\/j.ypmed.2020.106099","volume":"140","author":"DK Hatsukami","year":"2020","unstructured":"Hatsukami DK, Carroll DM. Tobacco harm reduction: past history, current controversies and a proposed approach for the future. Prev Med. 2020;140:106099.","journal-title":"Prev Med"},{"key":"864_CR5","unstructured":"Harm Reduction International. What is harm reduction? https:\/\/hri.global\/what-is-harm-reduction\/. Accessed 28 Jul 2023."},{"issue":"1","key":"864_CR6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12954-022-00722-5","volume":"19","author":"K Fagerstr\u00f6m","year":"2022","unstructured":"Fagerstr\u00f6m K. Can alternative nicotine products put the final nail in the smoking coffin? Harm Reduct J. 2022;19(1):131.","journal-title":"Harm Reduct J"},{"key":"864_CR7","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.toxrep.2021.01.014","volume":"8","author":"Y Akiyama","year":"2021","unstructured":"Akiyama Y, Sherwood N. Systematic review of biomarker findings from clinical studies of electronic cigarettes and heated tobacco products. Toxicol Rep. 2021;8:282\u201394.","journal-title":"Toxicol Rep"},{"key":"864_CR8","doi-asserted-by":"crossref","unstructured":"Rensch J, Edmiston J, Wang J, Jin X, Sarkar M. A randomized, controlled study to assess changes in biomarkers of exposures among adults who smoke that switch to oral nicotine pouch products relative to continuing smoking or stopping all tobacco use. J Clin Pharmacol. 2023;63(10):1108\u201318.","DOI":"10.1002\/jcph.2293"},{"key":"864_CR9","unstructured":"Office of the Federal Register, National Archives and Records Administration. 86 FR 55300 premarket tobacco product applications and recordkeeping requirements; final rule. In: U.S. Department of Health and Human Services, editor. Federal Register. Washington, D.C.: Office of the Federal Register, National Archives and Records Administration; 2021. p. 55300\u2013439."},{"issue":"1","key":"864_CR10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12954-021-00557-6","volume":"18","author":"C Hajat","year":"2021","unstructured":"Hajat C, Stein E, Ramstrom L, Shantikumar S, Polosa R. The health impact of smokeless tobacco products: a systematic review. Harm Reduct J. 2021;18(1):123.","journal-title":"Harm Reduct J"},{"issue":"8","key":"864_CR11","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/ntr\/ntq105","volume":"12","author":"KE Lund","year":"2010","unstructured":"Lund KE, McNeill A, Scheffels J. The use of snus for quitting smoking compared with medicinal products. Nicotine Tob Res. 2010;12(8):817\u201322.","journal-title":"Nicotine Tob Res"},{"issue":"7","key":"864_CR12","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/ntr\/ntr044","volume":"13","author":"E Lunell","year":"2011","unstructured":"Lunell E, Curvall M. Nicotine delivery and subjective effects of Swedish portion snus compared with 4 mg nicotine polacrilex chewing gum. Nicotine Tob Res. 2011;13(7):573\u20138.","journal-title":"Nicotine Tob Res"},{"issue":"1","key":"864_CR13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1477-7517-8-19","volume":"8","author":"B Rodu","year":"2011","unstructured":"Rodu B. The scientific foundation for tobacco harm reduction, 2006\u20132011. Harm Reduct J. 2011;8(1):19.","journal-title":"Harm Reduct J"},{"issue":"1","key":"864_CR14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1477-7517-9-10","volume":"9","author":"J Scheffels","year":"2012","unstructured":"Scheffels J, Lund KE, McNeill A. Contrasting snus and NRT as methods to quit smoking. An observational study. Harm Reduct J. 2012;9(1):10.","journal-title":"Harm Reduct J"},{"issue":"1","key":"864_CR15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12954-020-00405-z","volume":"17","author":"T Sohlberg","year":"2020","unstructured":"Sohlberg T, Wennberg P. Snus cessation patterns\u2014a long-term follow-up of snus users in Sweden. Harm Reduct J. 2020;17(1):62.","journal-title":"Harm Reduct J"},{"key":"864_CR16","unstructured":"Cyrus-Miller HF, Hamdouche S, Duddy S, McKinney WJ. Characterization of chew and park oral tobacco derived nicotine products. Society for Research on Nicotine and Tobacco 27th Annual Meeting, February 24, 2021; Virtual2021."},{"issue":"12","key":"864_CR17","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1111\/j.1360-0443.2003.00575.x","volume":"98","author":"S Shiffman","year":"2003","unstructured":"Shiffman S, Hughes JR, Di Marino ME, Sweeney CT. Patterns of over-the-counter nicotine gum use: persistent use and concurrent smoking. Addiction. 2003;98(12):1747\u201353.","journal-title":"Addiction"},{"issue":"3","key":"864_CR18","first-page":"425","volume":"10","author":"U Wadgave","year":"2016","unstructured":"Wadgave U, Nagesh L. Nicotine replacement therapy: an overview. Int J Health Sci (Qassim). 2016;10(3):425\u201335.","journal-title":"Int J Health Sci (Qassim)"},{"key":"864_CR19","doi-asserted-by":"crossref","first-page":"107632","DOI":"10.1016\/j.addbeh.2023.107632","volume":"140","author":"SM Gaiha","year":"2023","unstructured":"Gaiha SM, Lin C, Lempert LK, Halpern-Felsher B. Use, marketing, and appeal of oral nicotine products among adolescents, young adults, and adults. Addict Behav. 2023;140:107632.","journal-title":"Addict Behav"},{"issue":"4","key":"864_CR20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/ajad.13020","volume":"29","author":"N Plurphanswat","year":"2020","unstructured":"Plurphanswat N, Hughes JR, Fagerstrom K, Rodu B. Initial information on a novel nicotine product. Am J Addict. 2020;29(4):279\u201386.","journal-title":"Am J Addict"},{"issue":"9","key":"864_CR21","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1093\/ntr\/ntac073","volume":"24","author":"MS Gades","year":"2022","unstructured":"Gades MS, Alcheva A, Riegelman AL, Hatsukami DK. The role of nicotine and flavor in the abuse potential and appeal of electronic cigarettes for adult current and former cigarette and electronic cigarette users: a systematic review. Nicotine Tob Res. 2022;24(9):1332\u201343.","journal-title":"Nicotine Tob Res"},{"key":"864_CR22","unstructured":"National Institutes of Health [NIH]. Health Information National Trends Survey (2015) Survey Materials [OMB # 0925-0538]. In: U.S. Department of Health and Human Services, editor. Washington, D.C.: U.S. Department of Health and Human Services; 2015."},{"key":"864_CR23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.addbeh.2017.11.017","volume":"79","author":"LA Gibson","year":"2018","unstructured":"Gibson LA, Creamer MR, Breland AB, Giachello AL, Kaufman A, Kong G, et al. Measuring perceptions related to e-cigarettes: important principles and next steps to enhance study validity. Addict Behav. 2018;79:219\u201325.","journal-title":"Addict Behav"},{"issue":"Suppl 1","key":"864_CR24","first-page":"s50","volume":"29","author":"AR Kaufman","year":"2020","unstructured":"Kaufman AR, Persoskie A, Twesten J, Bromberg J. A review of risk perception measurement in tobacco control research. Tob Control. 2020;29(Suppl 1):s50\u20138.","journal-title":"Tob Control"},{"key":"864_CR25","unstructured":"U.S. Food and Drug Administration [FDA]. Final guidance for industry: tobacco products: principles for designing and conducting tobacco product perception and intention studies; 2022."},{"issue":"e1","key":"864_CR26","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1136\/tobaccocontrol-2016-053060","volume":"26","author":"CD Czoli","year":"2017","unstructured":"Czoli CD, Fong GT, Mays D, Hammond D. How do consumers perceive differences in risk across nicotine products? A review of relative risk perceptions across smokeless tobacco, e-cigarettes, nicotine replacement therapy and combustible cigarettes. Tob Control. 2017;26(e1):e49\u201358.","journal-title":"Tob Control"},{"key":"864_CR27","volume-title":"Scientific standards for studies on modified risk tobacco products","author":"Institute of Medicine [IOM]","year":"2012","unstructured":"Institute of Medicine [IOM]. Scientific standards for studies on modified risk tobacco products. Washington, DC: The National Academies Press; 2012."},{"key":"864_CR28","unstructured":"Magnani P, Beacher F, Wilson H, Badoglio S, Ramazzotti A. Intent to use for a new menthol HeatSticks variant in Japan. PMI Science [Internet]; 2017. https:\/\/www.pmiscience.com\/library\/publication\/Intent-to-Use-for-a-New-Menthol-HeatSticks-Variant-in-Japan."},{"key":"864_CR29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1477-7517-5-18","volume":"5","author":"B Rodu","year":"2008","unstructured":"Rodu B, Phillips CV. Switching to smokeless tobacco as a smoking cessation method: evidence from the 2000 National Health Interview Survey. Harm Reduct J. 2008;5:18.","journal-title":"Harm Reduct J"},{"key":"864_CR30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1617-9625-8-8","volume":"8","author":"EJ Mills","year":"2010","unstructured":"Mills EJ, Wu P, Lockhart I, Wilson K, Ebbert JO. Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation. A systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals. Tob Induc Dis. 2010;8:8.","journal-title":"Tob Induc Dis"},{"issue":"1","key":"864_CR31","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12955-018-0997-5","volume":"16","author":"S Cano","year":"2018","unstructured":"Cano S, Chrea C, Salzberger T, Alfieri T, Emilien G, Mainy N, et al. Development and validation of a new instrument to measure perceived risks associated with the use of tobacco and nicotine-containing products. Health Qual Life Outcomes. 2018;16(1):192.","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"864_CR32","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s10865-014-9605-2","volume":"38","author":"JK Pepper","year":"2015","unstructured":"Pepper JK, Emery SL, Ribisl KM, Rini CM, Brewer NT. How risky is it to use e-cigarettes? Smokers\u2019 beliefs about their health risks from using novel and traditional tobacco products. J Behav Med. 2015;38(2):318\u201326.","journal-title":"J Behav Med"},{"issue":"12","key":"864_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6812a1","volume":"68","author":"TW Wang","year":"2019","unstructured":"Wang TW, Gentzke AS, Creamer MR, Cullen KA, Holder-Hayes E, Sawdey MD, et al. Tobacco product use and associated factors among middle and high school students\u2014United States, 2019. MMWR Surveill Summ. 2019;68(12):1.","journal-title":"MMWR Surveill Summ"},{"key":"864_CR34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.addbeh.2017.09.002","volume":"77","author":"SP Feirman","year":"2018","unstructured":"Feirman SP, Donaldson EA, Parascandola M, Snyder K, Tworek C. Monitoring harm perceptions of smokeless tobacco products among U.S. adults: Health Information National Trends Survey 2012, 2014, 2015. Addict Behav. 2018;77:7\u201315.","journal-title":"Addict Behav"},{"key":"864_CR35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12954-015-0055-0","volume":"12","author":"MT Kiviniemi","year":"2015","unstructured":"Kiviniemi MT, Kozlowski LT. Deficiencies in public understanding about tobacco harm reduction: results from a United States national survey. Harm Reduct J. 2015;12:21.","journal-title":"Harm Reduct J"},{"issue":"8","key":"864_CR36","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1080\/10826084.2022.2076881","volume":"57","author":"JB Unger","year":"2022","unstructured":"Unger JB, Barker J, Cruz TB, Leventhal AM, Pentz MA. Lucy\u2014novel flavored nicotine gum, lozenges, and pouches: are they misleading consumers? Subst Use Misuse. 2022;57(8):1328\u201331.","journal-title":"Subst Use Misuse"},{"key":"864_CR37","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2147\/PROM.S11545","volume":"2","author":"SG Ferguson","year":"2011","unstructured":"Ferguson SG, Shiffman S, Gitchell JG. Nicotine replacement therapies: patient safety and persistence. Patient Relat Outcome Meas. 2011;2:111\u20137.","journal-title":"Patient Relat Outcome Meas"},{"issue":"14","key":"864_CR38","doi-asserted-by":"crossref","first-page":"7713","DOI":"10.3390\/ijerph18147713","volume":"18","author":"MT Bover Manderski","year":"2021","unstructured":"Bover Manderski MT, Steinberg MB, Wackowski OA, Singh B, Young WJ, Delnevo CD. Persistent Misperceptions about nicotine among US physicians: results from a randomized survey experiment. Int J Environ Res Public Health. 2021;18(14):7713.","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"864_CR39","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.amepre.2007.09.033","volume":"34","author":"S Shiffman","year":"2008","unstructured":"Shiffman S, Brockwell SE, Pillitteri JL, Gitchell JG. Use of smoking-cessation treatments in the United States. Am J Prev Med. 2008;34(2):102\u201311.","journal-title":"Am J Prev Med"},{"key":"864_CR40","first-page":"CD013308","volume":"4","author":"N Lindson","year":"2019","unstructured":"Lindson N, Chepkin SC, Ye W, Fanshawe TR, Bullen C, Hartmann-Boyce J. Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2019;4:CD013308.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"864_CR41","doi-asserted-by":"crossref","first-page":"e0178279","DOI":"10.1371\/journal.pone.0178279","volume":"12","author":"SH Zhu","year":"2017","unstructured":"Zhu SH, Anderson CM, Zhuang YL, Gamst AC, Kohatsu ND. Smoking prevalence in Medicaid has been declining at a negligible rate. PLoS ONE. 2017;12(5):e0178279.","journal-title":"PLoS ONE"},{"issue":"5","key":"864_CR42","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s40265-013-0038-y","volume":"73","author":"MJ Carpenter","year":"2013","unstructured":"Carpenter MJ, Jardin BF, Burris JL, Mathew AR, Schnoll RA, Rigotti NA, et al. Clinical strategies to enhance the efficacy of nicotine replacement therapy for smoking cessation: a review of the literature. Drugs. 2013;73(5):407\u201326.","journal-title":"Drugs"},{"issue":"2","key":"864_CR43","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.amepre.2008.09.039","volume":"36","author":"S Shiffman","year":"2009","unstructured":"Shiffman S, Ferguson SG, Strahs KR. Quitting by gradual smoking reduction using nicotine gum: a randomized controlled trial. Am J Prev Med. 2009;36(2):96-104 e1.","journal-title":"Am J Prev Med"},{"issue":"2","key":"864_CR44","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/ntr\/ntq215","volume":"13","author":"J Balmford","year":"2011","unstructured":"Balmford J, Borland R, Hammond D, Cummings KM. Adherence to and reasons for premature discontinuation from stop-smoking medications: data from the ITC Four-Country Survey. Nicotine Tob Res. 2011;13(2):94\u2013102.","journal-title":"Nicotine Tob Res"},{"issue":"11","key":"864_CR45","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1111\/add.15083","volume":"115","author":"S Shiffman","year":"2020","unstructured":"Shiffman S, Ferguson SG, Mao J, Scholl SM, Hedeker D, Tindle HA. Effectiveness of nicotine gum in preventing lapses in the face of temptation to smoke among non-daily smokers: a secondary analysis. Addiction. 2020;115(11):2123\u20139.","journal-title":"Addiction"},{"issue":"2","key":"864_CR46","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.addbeh.2009.09.024","volume":"35","author":"WT Dalton 3rd","year":"2010","unstructured":"Dalton WT 3rd, Klesges LM, Henderson L, Somes G, Robinson L, Johnson KC. Gender, smoking status, and risk behavior attitudes explain adolescents\u2019 patterns of nicotine replacement therapy use. Addict Behav. 2010;35(2):147\u201351.","journal-title":"Addict Behav"},{"key":"864_CR47","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jsat.2020.01.013","volume":"112","author":"DA Duarte","year":"2020","unstructured":"Duarte DA, Chen-Sankey JC, Dang K, Orozco L, Jewett B, Choi K. \u201cIsn\u2019t there a bunch of side effects?\u201d: a focus group study on the beliefs about cessation treatments of non-college educated young adult smokers. J Subst Abuse Treat. 2020;112:36\u201341.","journal-title":"J Subst Abuse Treat"},{"issue":"7","key":"864_CR48","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.2105\/AJPH.2016.303057","volume":"106","author":"G Kostygina","year":"2016","unstructured":"Kostygina G, England L, Ling P. New product marketing blurs the line between nicotine replacement therapy and smokeless tobacco products. Am J Public Health. 2016;106(7):1219\u201322.","journal-title":"Am J Public Health"},{"issue":"3","key":"864_CR49","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/ntr\/ntab154","volume":"24","author":"H Posner","year":"2022","unstructured":"Posner H, Romm KF, Henriksen L, Bernat D, Berg CJ. Reactions to sales restrictions on flavored vape products or all vape products among young adults in the United States. Nicotine Tob Res. 2022;24(3):333\u201341.","journal-title":"Nicotine Tob Res"},{"issue":"2","key":"864_CR50","first-page":"135","volume":"7","author":"S Kalkhoran","year":"2021","unstructured":"Kalkhoran S, Kalagher KM, Neil JM, Rigotti NA. Cigarette and e-cigarette use among smokers after a statewide e-cigarette sales ban. Tobacco Regul Sci. 2021;7(2):135\u2013439.","journal-title":"Tobacco Regul Sci"},{"issue":"8","key":"864_CR51","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/jamapediatrics.2021.0922","volume":"175","author":"AS Friedman","year":"2021","unstructured":"Friedman AS. A difference-in-differences analysis of youth smoking and a ban on sales of flavored tobacco products in San Francisco, California. JAMA Pediatr. 2021;175(8):863\u20135.","journal-title":"JAMA Pediatr"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-023-00864-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-023-00864-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-023-00864-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T06:23:10Z","timestamp":1700288590000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-023-00864-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,13]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["864"],"URL":"https:\/\/doi.org\/10.1186\/s12954-023-00864-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1500193\/v1","asserted-by":"object"}]},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,13]]},"assertion":[{"value":"29 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We followed practices Department of Health and Human Services regulations found at 45 CFR 46.101(b)(2) that exempts research involving survey procedures if information is not recorded in a manner that subjects can be identified (directly or through identifiers linked to the subjects), and if there is no reasonable risk (financial, criminal, civil, employability or reputational) if any subject\u2019s responses were to be disclosed outside the research. The Qualtrics panel online survey participants were recruited from double-opt-in panels (requesting to participate in studies and reconfirmed); no personal identifying information (such as name, age, birthdate or address) was collected by Voccii or shared with the research team. Subjects who had used the product had opted into a customer database, where they were offered an opportunity to participate in the study product purchaser survey via emails from Voccii, with no personal identifying information collected, kept or shared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CO has received consulting fees from companies to provide summaries of or advice on behavioral science research, including JUUL and Altria. NS has received consulting fees from a number of companies to provide advice and manage projects relating to tobacco product regulatory science. MB has received consulting fees from financial companies to validate their risk models. MB has family ties with one of the LUCY shareholders. KG has received consulting fees from a number of companies to manage projects relating to U.S. FDA applications. WM has received consulting fees from companies in various industries for advice on product regulatory science programs that determine product risks and support U.S. FDA applications.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"132"}}